Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-25 11:00 |
Alligator Bioscience presenterar den kliniska projektportföljen vid virtuell Fo…
|
Swedish | 101.9 KB | ||
| 2020-07-13 13:00 | Swedish | 2.5 MB | |||
| 2020-07-13 13:00 | English | 2.4 MB | |||
| 2020-06-23 08:30 |
Alligator Bioscience erhåller det första patentet för ATOR-1017
|
Swedish | 94.9 KB | ||
| 2020-06-23 08:30 |
Alligator Bioscience receives first patent approval for ATOR-1017
|
English | 95.0 KB | ||
| 2020-06-15 11:00 |
Alligator Bioscience appoints new CFO
|
English | 95.6 KB | ||
| 2020-06-15 11:00 |
Alligator Bioscience utser ny CFO
|
Swedish | 95.6 KB | ||
| 2020-06-10 15:00 |
Aptevo Therapeutics and Alligator Bioscience present new preclinical data for A…
|
English | 245.7 KB | ||
| 2020-06-10 15:00 |
Aptevo Therapeutics och Alligator Bioscience presenterar nya prekliniska data f…
|
Swedish | 110.6 KB | ||
| 2020-06-04 14:00 |
Alligator Bioscience and Scandion Oncology sign preclinical agreement to explor…
|
English | 101.3 KB | ||
| 2020-06-04 14:00 |
Alligator Bioscience och Scandion Oncology tecknar prekliniskt samarbetsavtal f…
|
Swedish | 100.2 KB | ||
| 2020-06-01 13:30 |
Alligator Biosciences samarbete med Biotheus Inc. går vidare med en andra delbe…
|
Swedish | 81.2 KB | ||
| 2020-06-01 13:30 |
Alligator Bioscience’s collaboration with Biotheus Inc. proceeds and second pay…
|
English | 80.5 KB | ||
| 2020-05-29 14:00 |
Alligator Bioscience presenterar ATOR-1015 på ASCO: Ytterligare positiva fas I-…
|
Swedish | 104.1 KB | ||
| 2020-05-29 14:00 |
Alligator Bioscience presents novel supportive Phase I data at ASCO for its CTL…
|
English | 101.6 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
